These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38063406)

  • 21. The anti-breast cancer stem cell properties of gold(i)-non-steroidal anti-inflammatory drug complexes.
    Johnson A; Olelewe C; Kim JH; Northcote-Smith J; Mertens RT; Passeri G; Singh K; Awuah SG; Suntharalingam K
    Chem Sci; 2023 Jan; 14(3):557-565. PubMed ID: 36741517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Copper(II) Phenanthroline Metallopeptide That Targets and Disrupts Mitochondrial Function in Breast Cancer Stem Cells.
    Laws K; Bineva-Todd G; Eskandari A; Lu C; O'Reilly N; Suntharalingam K
    Angew Chem Int Ed Engl; 2018 Jan; 57(1):287-291. PubMed ID: 29144008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A significantly non-toxic novel Cobalt(III) Schiff base complex induces apoptosis via G2-M cell cycle arrest in human breast cancer cell line MCF-7.
    Dasgupta S; Kar K; Barua A; Ghosh D; Kabi B; Dewan K; Chandra A
    Life Sci; 2022 Nov; 308():120963. PubMed ID: 36113731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Stem Cell and Bulk Cancer Cell Active Copper(II) Complexes with Vanillin Schiff Base Derivatives and Naproxen.
    Lu C; Eskandari A; Cressey PB; Suntharalingam K
    Chemistry; 2017 Aug; 23(47):11366-11374. PubMed ID: 28658520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential application of two cobalt (III) Schiff base complexes in cancer chemotherapy: Leads from a study using breast and lung cancer cells.
    Gowdhami B; Ambika S; Karthiyayini B; Ramya V; Kadalmani B; Vimala RTV; Akbarsha MA
    Toxicol In Vitro; 2021 Sep; 75():105201. PubMed ID: 34157415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
    Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
    Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
    Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
    BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment.
    Marijan S; Markotić A; Mastelić A; Režić-Mužinić N; Pilkington LI; Reynisson J; Čulić VČ
    Sci Rep; 2020 Jul; 10(1):11876. PubMed ID: 32680999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K; Eskandari A; Lu C; Suntharalingam K
    Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs.
    Chang JY; Lu GL; Stevenson RJ; Brothers PJ; Clark GR; Botting KJ; Ferry DM; Tercel M; Wilson WR; Denny WA; Ware DC
    Inorg Chem; 2013 Jul; 52(13):7688-98. PubMed ID: 23773210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic cobalt (III) Schiff base complexes: in vitro anti-proliferative, oxidative stress and gene expression studies in human breast and lung cancer cells.
    Gowdhami B; Manojkumar Y; Vimala RTV; Ramya V; Karthiyayini B; Kadalmani B; Akbarsha MA
    Biometals; 2022 Feb; 35(1):67-85. PubMed ID: 34935092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dithiacyclam-coordinated silver(i) polymer with anti-cancer stem cell activity.
    Johnson A; Iffland L; Singh K; Apfel UP; Suntharalingam K
    Dalton Trans; 2021 May; 50(17):5779-5783. PubMed ID: 33890607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tri-metallic palladium complex with breast cancer stem cell potency.
    Eskandari A; Kundu A; Johnson A; Karmakar S; Ghosh S; Suntharalingam K
    Dalton Trans; 2020 Apr; 49(14):4211-4215. PubMed ID: 32186576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
    Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs.
    Chang JY; Stevenson RJ; Lu GL; Brothers PJ; Clark GR; Denny WA; Ware DC
    Dalton Trans; 2010 Dec; 39(48):11535-50. PubMed ID: 21103540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypyridyl Zinc(II)-Indomethacin Complexes with Potent Anti-Breast Cancer Stem Cell Activity.
    Rundstadler TK; Eskandari A; Norman SM; Suntharalingam K
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30181492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD10
    Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
    Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
    Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
    Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.